BF Biosciences Ltd

KAR:BFBIOHealth TechnologyPSX:ALLSHRPSX:KMIALLSHR

Rs 126.98+0.72%LiveIn session · ≈ AED 1.69 · Market cap $41.36M · Next earnings Wed 2 Dec

BFBIO · Cash flow · TradingHolo

PKR millions	FY2021	FY2022	FY2023	FY2024	FY2025	TTM	YoY
Depreciation & amortization	23.4	28.3	34.3	36.1	193.6	270.7	+39.8%
Change in working capital	(76.9)	(83.3)	(422.4)	(78.5)	(394.3)	(804.8)	−104.1%
Operating cash flow	583.7	292.0	(232.9)	519.5	282.6	306.1	+8.3%
Capital expenditure	(941.1)	(1,130.2)	(1,970.0)	(143.1)	(329.5)	(513.9)	−56.0%
Dividends paid	0.0	0.0	0.0	0.0	0.0	0.0	—
Free cash flow	(357.4)	(838.1)	(2,201.3)	376.4	(46.9)	(207.9)	−342.8%

PKR millionsUpdated 30 Sep 2025 ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

TTM ends 2026-03-31 and uses four consecutive reported quarters.